tiprankstipranks
Trending News
More News >
Tryptamine Therapeutics Limited (AU:ENP)
ASX:ENP
Australian Market

Tryptamine Therapeutics (ENP) Income Statement

Compare
14 Followers

Tryptamine Therapeutics Income Statement

Last quarter (Q4 2024), Tryptamine Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Tryptamine Therapeutics's net income was AU$-1.31M. See Tryptamine Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
AU$ 0.00AU$ 0.00AU$ 618.57KAU$ 99.73KAU$ 0.00
Gross Profit
AU$ -54.34KAU$ -6.77KAU$ 618.57KAU$ 99.73KAU$ -1.01M
Operating Expenses
AU$ 6.68MAU$ 4.96MAU$ 10.21MAU$ 14.21MAU$ 11.66M
Depreciation and Amortization
AU$ 54.34KAU$ 6.77KAU$ 1.70MAU$ 1.73MAU$ 1.01M
EBITDA
AU$ -5.27MAU$ -6.70MAU$ -5.10MAU$ -8.27MAU$ -11.66M
Operating Income
AU$ -6.73MAU$ -4.97MAU$ -9.59MAU$ -14.11MAU$ -12.67M
Other Income/Expenses
AU$ -184.29KAU$ -2.28MAU$ 2.46MAU$ 4.03MAU$ 118.56K
Pretax Income
AU$ -6.91MAU$ -7.25MAU$ -7.13MAU$ -10.08MAU$ -12.55M
Net Income
AU$ -5.33MAU$ -6.14MAU$ -7.13MAU$ -10.08MAU$ -8.47M
Per Share Metrics
Basic EPS
AU$ 0.00AU$ -0.01AU$ -0.09AU$ -0.14AU$ -0.14
Diluted EPS
AU$ 0.00AU$ -0.01AU$ -0.09AU$ -0.14AU$ -0.14
Weighted Average Shares Outstanding
1.38B 506.71M 78.76M 71.08M 59.05M
Weighted Average Shares Outstanding (Diluted)
1.38B 506.71M 78.76M 71.08M 59.05M
Currency in AUD

Tryptamine Therapeutics Earnings and Revenue History